QuantaLife, a US-based technology company for human genomics, has raised $17.2m in its series B round from a consortium including Mérieux Développement, the corporate venturing company of Institut Mérieux, a French industrial holding company.
Venture capital firm Paladin Capital Group led the round, and was joined by peer Vital Financial, as well as Mérieux. Paladin had provided an undisclosed sum in QuantaLife’s A round.
Francois Valencony, managing director of Merieux Developpement, which plans to invest €70m as a minority…
